Vivek Roy
Impact in
- Hematology top 0.2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 1%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 124
- Multiple Myeloma Research and Treatments 91
- Hematopoietic Stem Cell Transplantation 23
- Chronic Myeloid Leukemia Treatments 12
-
- Protein Degradation and Inhibitors 36
- Co-authors
- Robert C. Flanigan (2 shared papers)Nikhil C. Munshi (3 shared papers)J. R. Caton (1 shared paper)E. David Crawford (1 shared paper)Scott I. Bearman (1 shared paper)Brent A. Blumenstein (1 shared paper)Sydney E. Salmon (1 shared paper)Patrick C. McGrath (1 shared paper)
- Journals
- Blood (63 papers)Biology of Blood and Marrow Transplantation (14 papers)Journal of Clinical Oncology (10 papers)Leukemia (8 papers)American Journal of Hematology (7 papers)
- Partner nations
- United StatesUnited KingdomIndia
In The Last Decade
Vivek Roy
192 papers receiving 6.3k citations
Vivek Roy's Hit Papers
Peers
Comparison fields: 5 of 116
- Hematology 2.8k
- Oncology 2.0k
- Genetics 725
- Pulmonary and Respiratory Medicine 1.4k
- Cancer Research 562
Countries citing papers authored by Vivek Roy
This map shows the geographic impact of Vivek Roy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivek Roy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivek Roy more than expected).
Fields of papers citing papers by Vivek Roy
This network shows the impact of papers produced by Vivek Roy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivek Roy. The network helps show where Vivek Roy may publish in the future.
Co-authors
The 25 scholars most cited alongside Vivek Roy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 207 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell Cancer Hit paper breakdown → | 2001 | 1288 |
| 2 | 2007 | 260 | |
| 3 | 2009 | 241 | |
| 4 | 2014 | 210 | |
| 5 | 2014 | 205 | |
| 6 | 2010 | 179 | |
| 7 | 2004 | 161 | |
| 8 | 2007 | 148 | |
| 9 | 2011 | 148 | |
| 10 | 2008 | 127 | |
| 11 | 2007 | 120 | |
| 12 | 1997 | 120 | |
| 13 | 2007 | 110 | |
| 14 | 2014 | 108 | |
| 15 | 2009 | 100 | |
| 16 | 2012 | 95 | |
| 17 | 2001 | 90 | |
| 18 | 2011 | 84 | |
| 19 | 1999 | 83 | |
| 20 | 2006 | 78 |
About Vivek Roy
Vivek Roy is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Public Health, Environmental and Occupational Health, having authored 207 papers that have together received 6.5k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (91 papers), Protein Degradation and Inhibitors (36 papers), Chronic Lymphocytic Leukemia Research (31 papers), Cancer Treatment and Pharmacology (26 papers), Hematopoietic Stem Cell Transplantation (23 papers), Peptidase Inhibition and Analysis (16 papers), Lymphoma Diagnosis and Treatment (13 papers) and Chronic Myeloid Leukemia Treatments (12 papers). The work is most often cited by research in Hematology (2.8k citations), Oncology (2.0k citations), Genetics (725 citations), Pulmonary and Respiratory Medicine (1.4k citations) and Cancer Research (562 citations). Vivek Roy has collaborated with scholars based in United States, United Kingdom and India. Frequent co-authors include Robert C. Flanigan, Nikhil C. Munshi, J. R. Caton, E. David Crawford, Scott I. Bearman, Brent A. Blumenstein, Sydney E. Salmon, Patrick C. McGrath, Shaji Kumar and Angela Dispenzieri. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Leukemia and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.